Is Aktis Oncology, Inc. (AKTS) a Buy, Sell, or Hold?
NASDAQ : AKTS
Aktis Oncology, Inc.
$26 USD
$0.82 (3.28%)
- Volume
- 432.46K
- Average Volume
- 345.14K
- Market Capitalization
- $1.39B
- P/E Ratio
- -42.62
- Dividend Yield
- 0.00%
- Price Target
- $35.00
- Year High
- $34.19
- Year Low
- $14.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.49
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.07%
Investors Holding
4
change: -65 | last: 69
Increased Positions
3
change: -66 | last: 69
Reduced Positions
0
change: 0 | last: 0
New Positions
3
change: -66 | last: 69
Sold Positions
68
change: 68 | last: 0
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: 0 | last: 0
Total Invested
1.33M
AKTS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $22.40 | 52.52M | $1.18B | $37.78M | $11.55M | $1.15B |
| 2024-12-31 | $22.40 | 34.86M | $780.97M | $37.16M | $12.01M | $755.82M |
| 2023-12-31 | $22.40 | 34.86M | $780.97M | $29.51M | $13.4M | $764.86M |
| 2022-12-31 | $22.40 | 34.86M | $780.97M | $128.6M | $1.78M | $654.15M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17.89 | 55.28M | $988.89M | $371.63M | $11.58M | $628.83M |
| 2025-12-31 | $22.40 | 53.4M | $1.2B | $37.78M | $11.55M | $1.17B |
| 2025-09-30 | $22.40 | 52.52M | $1.18B | $180.25M | $11.86M | $1.01B |
| 2024-12-31 | $22.40 | 52.52M | $1.18B | $37.16M | $12.01M | $1.15B |
| 2024-09-30 | $22.40 | 34.86M | $780.97M | $224.64M | $12.41M | $568.74M |